リスク警告: 当社の製品はレバレッジを使用しており、高いリスクが伴います。投資元本全額を失う可能性もあります。そのような製品はすべての投資家に適しているとは限りません。関連するリスクを十分に理解することが極めて重要です。
  • サポート
  • 機関投資家向け
リスク警告: 当社の製品はレバレッジを使用しており、高いリスクが伴います。投資元本全額を失う可能性もあります。そのような製品はすべての投資家に適しているとは限りません。関連するリスクを十分に理解することが極めて重要です。
  • サポート
  • 機関投資家向け
リスク警告: 当社の製品はレバレッジを使用しており、高いリスクが伴います。投資元本全額を失う可能性もあります。そのような製品はすべての投資家に適しているとは限りません。関連するリスクを十分に理解することが極めて重要です。
リスク警告:レバレッジ商品は高いリスクを伴い、投資元本をすべて失う可能性があります。投資を行う前に、リスクを十分に理解してください。
リスク警告:レバレッジ商品は高いリスクを伴い、投資元本をすべて失う可能性があります。投資を行う前に、リスクを十分に理解してください。

AMD, Palantir, and Super Micro in Focus

U.S. stocks are in focus today as investors track key corporate updates across technology, healthcare, and energy. Palantir gained after raising its full-year forecast, while Hims came under pressure following its break with Novo Nordisk and weaker sales. BP also moved higher, supported by improved margins and fresh cost-cutting measures.

Key Points:

  • Palantir rises 6% after lifting its full-year forecast.
  • Hims dropped 10% following a break with Novo Nordisk and disappointing sales.
  • BP gains 2.5% on improved margins and announced cost cuts.

Palantir (PLTR): Momentum from Upward Guidance

Palantir gained 6% in premarket trading after reporting quarterly earnings that surpassed expectations and raising its full-year outlook. The company continues to benefit from growing demand for its AI-driven software offerings.

Hims & Hers (HIMS), Novo Nordisk (NVO): Declines on Partnership Fallout and Weak Results

Shares of Hims fell over 10% after missing revenue estimates. The stock was further pressured by tensions with Novo Nordisk, sparked by Hims’ offering of generic weight-loss medications via its platform.

Vertex Pharmaceuticals (VRTX): Setback Following Clinical Trial Decision

Vertex declined 14% in after-hours trading after announcing it will halt development of its experimental pain treatment, despite promising early-stage data. The decision underscores the company’s reliance on its late-stage pipeline.

DuPont de Nemours (DD): Strong Sales and Upbeat Outlook

DuPont rose 7% in premarket trading after exceeding sales projections and issuing guidance above analyst expectations. Its specialty materials division showed resilience amid uneven end-market demand.

BP (BP), Diageo (DEO): Gains Despite External Pressures

BP advanced 2.5% after reporting stronger profitability metrics and introducing additional cost-saving initiatives. Diageo added 2% despite forecasting a $200 million annual tariff impact.

Advanced Micro Devices (AMD), Super Micro (SMCI), Snap (SNAP): Key Earnings Ahead

Investors are watching earnings reports from AMD, Super Micro Computer, and Snap, all due Tuesday. These results will offer insight into demand trends for high-performance chips, server infrastructure, and social media platforms amid a still-recovering tech landscape.

Related posts

How to Invest During High Inflation

How to Invest During High Inflation

Your investment acco […]

Nvidia Earnings

Nvidia Earnings: AI Faces a New Test

Nvidia reports its f […]

Technical Analysis-EN

S&P 500 Faces Key Test

U.S. equity futures […]